Workflow
WUXI BIO(WXXWY)
icon
Search documents
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year
Prnewswire· 2024-07-10 05:30
SHANGHAI, July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has again been named as a constituent company of the FTSE4Good Index Series. This marks the fourth consecutive year the company has been included in the Index for its outstanding sustainability performance. In line with the United Nations Sustainable Development Goals, WuXi Biologics has been making steady progress in pursuing sus ...
药明生物20240619
2024-06-21 13:54
这个情况是因为我们公司的全基地系统在每份基地到期后会移动为所有的可能卖员的股票用于cover他们的个人税这是进行自动的一个设置而且是适用于我们公司所有的员工并非周总和周总自己的一个个人卖员的一个行为这个请大家跟大家澄清一下 第二个是因为最近的市场非常的敏感,而且监管机构对合规的行为将会更加严格,恳请大家不要将接下来的Q&A的内容对外传播,谢谢大家 感谢王立强博士来自天津的投资者我想提两个问题第一个问题就是说因为现在邀请之后由于这个地缘政治的原因受到美国的法案影响然后我们的水值从高峰的五六千亿港元港币的话现在已经跌到了低于五百亿港元 因为之前我们管理层一直在持续地检测而有13次的检测然后我们从这个账户的70%现在降到了可能百分之十几我就想到了就是作为投资者的话我们很看好这个药瓶生物股未来的发展因为上周我也参加了药瓶康格的这个会康格的这个管理层和美国之所以是采用我们药瓶是因为我们太优秀了 那我觉得我们在作为这个生物大户的方面我们要比这个化学的这个分子团更有这个未来的发展和优势作为投资者更看好我们药品的发展但是因为之前我们管理层一直在减持而且现在实质特别低我想问一下管理层我们会不会像我比较担心的就是说在这种这个 估 ...
药明生物24年股东大会
2024-06-20 03:30
Summary of Conference Call Transcript Company/Industry Involved - The discussion pertains to the company's stock management practices and compliance with regulatory requirements. Core Points and Arguments - The company has an automatic system in place that sells a portion of stock for all employees to cover their personal income tax obligations. This is a standard procedure applicable to all employees, not a personal decision by individuals [1] - There is heightened sensitivity in the market recently, and regulatory bodies are closely monitoring compliance behaviors [1] Other Important but Possibly Overlooked Content - The clarification regarding the automatic stock sale is crucial to prevent misunderstandings about individual stock selling actions by employees [1]